Atlas Trials

Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism

Clinical trial NCT03337646 · COMPLETED

Trial details

NCT number
NCT03337646
Sponsor
JPM van Stralen Medicine Professional
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder
Start date
2018-09-26
Primary completion
2023-03-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.